Skip to main content
High RiskFDAfda-F-1116-2016OTHER

GoGo squeeZ, non-organic Apple Sauce pouches, 3.2 oz., 12x4, Apple/Peach/SweetPotato (Pedal Pedal Peach) Flavor Variety

Category
Units Affected
4,780,784
Recall Date
March 4, 2016
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1116-2016.

Materne North America Corp. is voluntarily recalling specific packages of GoGo squeeZ¿ applesauce pouches due to potential adulteration from food product residue.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1116-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Materne North America Corp or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1116-2016.

Materne North America Corp

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Materne North America Corp Recall FAQ

Materne North America Corp is the subject of a food safety report: GoGo squeeZ, non-organic Apple Sauce pouches, 3.2 oz., 12x4, Apple/Peach/SweetPotato (Pedal Pedal Peach) Flavor Variety. The notice was published on March 4, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 4,780,784 units are potentially affected.